Evidence map›Paper›PMID 42079634›Full record

SynthesisFrontiers in immunology2026

Worldwide research trends on the

Liwei Li, Fuqing Cai, Shikai Liu, Peng Peng, Jingrong Liang, Zheng Liu, Hengyuan Xu, Weijiu Mo, Jiamin Qin, Sufan Tang and 12 more

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Liwei Li *Department of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Fuqing Cai *Department of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Shikai Liu *Department of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Peng PengDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jingrong LiangDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zheng LiuDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Hengyuan XuDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Weijiu MoDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jiamin QinDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Sufan TangDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Huaqiang RuanDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jinxiu ZhangDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Chenghai LiangDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Shiquan LiuDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Mengbin QinDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Rongbin QinDepartment of Gastroenterology, 923 Hospital of People's Liberation Army Joint Logistics Support Force, Nanning, China.
Feilong LuoDepartment of Gastroenterology, 923 Hospital of People's Liberation Army Joint Logistics Support Force, Nanning, China.
Guang XiongDepartment of Geriatric Endocrinology and Metabolism, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Chongze YangDepartment of Radiology, Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University, Nanning, China.
Yan GengDepartment of Gastroenterology, 923 Hospital of People's Liberation Army Joint Logistics Support Force, Nanning, China.
Jun ZouDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jiean HuangDepartment of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The impact of Methods: Articles were collected from the Web of Science Core Collection, Scopus, and PubMed (2000-2025) and analyzed using bibliometrix, VOSviewer, and CiteSpace. Analysis of 1,592 publications reveals a distinct three-phase evolutionary structure in the field. Results and discussion: Geographically led by China and the USA, the research focus has undergone a paradigm shift: evolving from an initial "infection and eradication" phase, through a transitional "dysbiosis and ecological intervention" phase, to the current "tumor-immunity axis" hotspot. Recent high-strength citation bursts for terms like "

Indexed as

Gastrointestinal MicrobiomeHelicobacter InfectionsHelicobacter pyloriAnimalsBibliometricsDysbiosisHumansbibliometricgut microbiomeHelicobacter pyloriimmunotherapytumor microbiome

Identifiers

PMID42079634
PMCPMC13128404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.